Sulfisoxazole from Germany
Sulfisoxazole is a short-acting sulfonamide antibiotic effective against a wide range of gram-positive and gram-negative bacteria, commonly used in pediatric ear infections and urinary tract infections. It qualifies for HTS 2935.90.60.00 as a sulfonamide drug meeting Chapter 29 criteria for separate chemically defined organic compounds used pharmaceutically. The molecule features the classic p-aminobenzenesulfonamide structure.
Duty Rate — Germany → United States
15%
Rate breakdown
9903.04.628.5%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.900%Articles of aluminum, of steel or of copper or derivative aluminum or steel articles; passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; parts of passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; medium- and heavy-duty vehicles; parts of medium- and heavy-duty vehicles; wood products; patented pharmaceutical articles; and semiconductor articles, as provided in subdivision (f) of U.S. note 52 to this subchapter
Import Tips
• Submit FDA registration and drug listing numbers for the manufacturing facility to expedite clearance
• Include microbial limit testing results as sulfonamides are prone to contamination issues during import
• Avoid bulk packaging that suggests industrial use to maintain pharmaceutical classification